Historical, clinical, and dermoscopic characteristics of thin nodular melanoma

Archives of Dermatology

Volumn 146, Issue 3, 2010, Pages 311-318

  Kalkhoran, Sara ^a   Milne, Olivia ^b   Zalaudek, Iris ^c   Puig, Susana ^d   Malvehy, Josep ^d   Kelly, John W ^b   Marghoob, Ashfaq A ^e  

^a STONY BROOK UNIVERSITY   (United States)

^b ALFRED HOSPITAL   (Australia)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d HOSPITAL CLÍNIC   (Spain)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPILUMINESCENCE MICROSCOPY; FEMALE; HUMAN; MALE; MELANOMA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SKIN DEFECT; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; DERMOSCOPY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 77949376847     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.369     Document Type: Article

References (29)

1. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138(5):609-614.
2. Murray CS, Stockton DL, Doherty VR. Thick melanoma: the challenge persists. Br J Dermatol. 2005;152(1):104-109.
3. Liu W, Dowling JP, Murray WK, et al. Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. Arch Dermatol. 2006;142(12):1551-1558.
4. Richard MA, Grob JJ, Avril MF, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol. 1999;135(3):269-274.
5. Warycha MA, Christos PJ, Mazumdar M, et al. Changes in the presentation of nodular and superficial spreading melanomas over 35 years. Cancer. 2008;113(12):3341-3348.
6. Segura S, Pellacani G, Puig S, et al. In vivo microscopic features of nodular melanomas: dermoscopy, confocal microscopy, and histopathologic correlates. Arch Dermatol. 2008;144(10):1311-1320.
7. Zalaudek I, Marghoob AA, Scope A, et al. Three roots of melanoma. Arch Dermatol. 2008;144(10):1375-1379.
8. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135-2147.
9. Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol. 2003;48(5):694-701.
10. Bergenmar M, Hansson J, Brandberg Y. Detection of nodular and superficial spreading melanoma with tumour thickness ≤2.0 mm: an interview study. Eur J Cancer Prev. 2002;11(1):49-55.
11. Nachbar F, Stolz W, Merkle T, et al. The ABCD rule of dermatoscopy: high prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol. 1994;30(4):551-559.
12. Kelly JW. Nodular melanoma: how current approaches to early detection are failing. J Drugs Dermatol. 2005;4(6):790-793.
13. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969;29(3):705-727.
14. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130-151.
15. Moynihan GD. The 3 Cs of melanoma: time for a change? J Am Acad Dermatol. 1994;30(3):510-511.
16. Henning JS, Dusza SW, Wang SQ, et al. The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy. J Am Acad Dermatol. 2007; 56(1):45-52.
17. Menzies SW, Ingvar C, McCarthy WH. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res. 1996;6(1):55-62.
18. Menzies SW, Kreusch J, Byth K, et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol. 2008;144(9):1120-1127.
19. Benvenuto-Andrade C, Dusza SW, Agero AL, et al. Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions. Arch Dermatol. 2007;143(3):329-338.
20. Zalaudek I, Ferrara G, Argenziano G, Kerl H. Three important rules in dermatoscopy [in German]. J Dtsch Dermatol Ges. 2007;5(5):422-423.
21. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
22. Ries L, Melbert D, Krapcho M, et al. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute; based on November 2007 SEER data submission, posted to the SEER web site 2008. http://seer.cancer.gov/csr/ 1975-2005/. Accessed January 16, 2008.
23. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129(7):1666-1674.
24. Schneider JS, Moore DH II, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol. 2008;58(5):741-749.
25. Roetzheim RG, Pal N, van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol. 2000;43(2 Pt 1):211-218.
26. Tejera-Vaquerizo A, Mendiola-Fernandez M, Fernandez-Orland A, Herrera-Ceballos E. Thick melanoma: the problem continues. J Eur Acad Dermatol Venereol. 2008;22(5):575-579.
27. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA. 1997;277(18):1439-1444.
28. Puig S, Argenziano G, Zalaudek I, et al. Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg. 2007;33(10):1262-1273.
29. Resneck JS Jr, Lipton S, Pletcher MJ. Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists. J Am Acad Dermatol. 2007;57(6):985-989.